Home/Filings/4/0001753926-24-001135
4//SEC Filing

Lang Eric 4

Accession 0001753926-24-001135

CIK 0001919246other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 8:05 PM ET

Size

5.5 KB

Accession

0001753926-24-001135

Insider Transaction Report

Form 4
Period: 2024-06-14
Lang Eric
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2024-06-14+130,000154,223 total
    Exercise: $1.30Exp: 2034-06-14Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]On June 14, 2024, the Reporting Person was granted stock options to purchase 130,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.

Documents

1 file

Issuer

Chromocell Therapeutics Corp

CIK 0001919246

Entity typeother

Related Parties

1
  • filerCIK 0001984967

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 8:05 PM ET
Size
5.5 KB